How the PSD3 Protein Helps Esophageal Tumors Hide from the Immune System

Summary

Esophageal squamous cell carcinoma, or ESCC, is a difficult disease to treat because it is notoriously good at hiding from the body's immune system. Scientists have known that a cellular recycling process called autophagy plays a role in this disappearing act. Now, researchers have identified a specific protein called PSD3 that appears to be a major accomplice. When looking at ESCC tissues, the team found that PSD3 is highly active, and patients with elevated levels of this protein tend to face worse clinical outcomes.

To understand how this protein works, researchers performed experiments to block or knock down PSD3 in both human and mouse cell models. Without PSD3, the cancer cells could not carry out their normal recycling process efficiently. Even more importantly, blocking PSD3 caused an increase in MHC-I proteins. These proteins act like tiny red flags on the surface of a cell, signaling to the immune system that a threat is present. In mouse models, this increase in MHC-I proteins successfully drew more cancer-fighting immune cells into the tumors.

The researchers also discovered that PSD3 works in a complex chain of events. When they silenced another recycling gene called ATG7 after blocking PSD3, it selectively restored a specific immune molecule called HLA-E, though other similar molecules remained unchanged. While these findings are exciting, the researchers note that this work is still in its early stages. Because the experiments were conducted in laboratory cell cultures and animal models, scientists need to do much more research to map out the exact chemical pathways and immune functions before this knowledge can be translated to human patients.

The story in numbers.

Autophagy-related proteins co-immunoprecipitated with PSD3 (ATG7, BAG3, TBK1)

3

HLA class I variants analyzed post-ATG7 silencing (HLA-E, HLA-ABC, HLA-F)

3